colorectal cancer

Showing NaN - NaN of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

Completed
  • Pancreatic Cancer
  • +2 more
  • AMG820 and pembrolizumab
  • Atlanta, Georgia
  • +14 more
Jan 18, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Colorectal Cancer Trial in Worldwide (favezelimab/pembrolizumab, regorafenib, TAS-102)

Active, not recruiting
  • Colorectal Cancer
  • favezelimab/pembrolizumab
  • +2 more
  • Washington, District of Columbia
  • +151 more
Oct 12, 2022

Integrated Molecular Profiling in Advanced Cancers Trial

Active, not recruiting
  • Breast Cancer
  • +9 more
    • Toronto, Ontario, Canada
      Princess Margaret Hospital
    Sep 26, 2022

    Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

    Active, not recruiting
    • Advanced Solid Tumors
    • +7 more
    • Duarte, California
    • +87 more
    Aug 19, 2022

    Colorectal Cancer, Pancreatic Cancer, Gastric Cancers Trial in Canada, Korea, Republic of, United States (BOLD-100 in

    Recruiting
    • Colorectal Cancer
    • +3 more
    • BOLD-100 in combination with FOLFOX Chemotherapy
    • Santa Monica, California
    • +12 more
    Aug 18, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • Toronto, Ontario, Canada
      University Health Network - Princess Margaret Cancer Centre
    Aug 16, 2022

    Urinary Bladder Tumors, Colorectal Cancer, NSCLC Trial in Worldwide (AZD8853, Zirconium-89 crefmirlimab berdoxam)

    Recruiting
    • Urinary Bladder Neoplasms
    • +2 more
    • AZD8853
    • Zirconium-89 crefmirlimab berdoxam
    • New Haven, Connecticut
    • +14 more
    Aug 8, 2022

    Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

    Not yet recruiting
    • Endometrial Cancer
    • +4 more
    • Datopotamab deruxtecan (Dato-DXd)
    • +8 more
    • Los Angeles, California
    • +52 more
    Aug 3, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Nivolumab
    • +3 more
    • Birmingham, Alabama
    • +101 more
    Jun 13, 2022

    Marathon of Hope Cancer Centres Network Study for Ontario

    Recruiting
    • Breast Cancer
    • +11 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jun 6, 2022

      Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

      Completed
      • Colorectal Cancer
      • +3 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 12, 2022

      Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

      Recruiting
      • Metastatic Uveal Melanoma
      • +3 more
      • Scottsdale, Arizona
      • +13 more
      May 10, 2022

      Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)

      Completed
      • Colorectal Cancer
      • Birmingham, Alabama
      • +210 more
      Mar 30, 2022

      Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

      Recruiting
      • Breast Cancer
      • +10 more
        • Hamilton, Ontario, Canada
        • +6 more
        Apr 21, 2022

        Comprehensive Genomic Profiling of Colorectal Cancer Isolated

        Active, not recruiting
        • Colorectal Cancer
        • +2 more
          • Vancouver, British Columbia, Canada
          • +1 more
          Apr 13, 2022

          Colorectal Cancer, Liver Metastases Trial in Toronto (live donor liver transplantation)

          Recruiting
          • Colorectal Cancer
          • Liver Metastases
          • live donor liver transplantation
          • Toronto, Ontario, Canada
            Toronto General Hospital
          Mar 31, 2022

          Colorectal Cancer Trial in Canada, Puerto Rico, United States (celecoxib, 5-fluorouracil, )

          Active, not recruiting
          • Colorectal Cancer
          • Mobile, Alabama
          • +841 more
          Mar 18, 2022

          Colorectal Cancer, Lung Cancer, Solid Tumor Trial in Ottawa, Toronto (capecitabine, carboplatin, cediranib maleate)

          Completed
          • Colorectal Cancer
          • +2 more
          • Ottawa, Ontario, Canada
          • +1 more
          Mar 14, 2022

          Colorectal Cancer Trial in Worldwide (Nivolumab, Oxaliplatin, Leucovorin)

          Active, not recruiting
          • Colorectal Cancer
          • Nivolumab
          • +4 more
          • Birmingham, Alabama
          • +48 more
          Mar 2, 2022

          Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

          Completed
          • Breast Cancer
          • +5 more
          • Nashville, Tennessee
          • +11 more
          Jan 28, 2022